Picture of Larimar Therapeutics logo

LRMR — Larimar Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Larimar Therapeutics Q4 Net Income USD -12.993 Million

Mar 14 (Reuters) - Larimar Therapeutics Q4 operating expenses USD 14.162
million.
* Q4 basic EPS USD -0.3
* Q4 income from operations USD -14.162 million

Recent news on Larimar Therapeutics

See all news